Avantor, Inc. (AVTR)
Listed on NYSE • Basic Materials / Chemicals - Specialty
Overview
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Explore More Data
Key Information
Symbol:
AVTR
CEO:
Michael Stubblefield
Exchange:
NYSE
CIK:
0001722482
Website:
https://www.avantorsciences.com
SEC Filings:
View SEC →
Stock Snapshot (Updated: Nov 05 04:00 PM EST)
Price
11.58
Change
0
Change %
0.00%
Open
11.44
Previous Close
11.58
High
11.7
Low
11.32
Volume
7,079,230
Market Cap
7,895,415,808
EV/EBITDA
13.14
Capital Structure (Updated: Nov 05 04:00 PM EST)
Shares Outstanding
681,814,859
FloatShares
663,924,037
Float Ratio
97.38%
Shares Short
23,465,890
Short Percent Of Float
The percent of float shares currently sold short. Reflects market sentiment and risk of a short squeeze.
4.68%
Short Ratio
Days needed to cover all short positions. Indicates short-selling pressure.
2.47 trading days
Held Percent Insiders
1.37%
Held Percent Institutions
107.91%
Calendar Events (Upcoming Earnings & Revenue Forecasts)
| Earnings | |
| Earnings Date | 2025-10-29 |
| Earnings Call | 2025-10-29 |
| Avg EPS Estimate | 0.2159 |
| Low EPS Estimate | 0.2044 |
| High EPS Estimate | 0.228 |
| Revenue | |
| Avg Revenue Forecast | 1,636,251,350 |
| Low Revenue Forecast | 1,615,804,800 |
| High Revenue Forecast | 1,653,280,000 |
AVTR Liquidity Indicators Shows key metrics that reflect cash availability and short-term payment ability
| Field | Value | Description |
|---|---|---|
| Cash Holdings | $251,900,000 | Cash on hand, which directly shows a company's ability to meet short-term obligations. |
| Quick Ratio | 0.877 | The quick ratio, which excludes inventory, measures short-term solvency; a value above 1 is considered relatively safe. |
| Current Ratio | 1.488 | The current ratio, calculated as current assets divided by current liabilities; the higher the value, the better the liquidity. |
| Total Debt | $3,857,900,032 | Total liabilities, used together with cash and liquidity ratios to assess debt burden. |
AVTR Profitability Indicators Shows key metrics that reflect overall earnings, margins, and core business profitability
| Field | Value | Description |
|---|---|---|
| EBITDA | $1,080,600,064 | EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), which measures the profitability of core operations. |
| Operating Cash Flow | $644,400,000 | Operating cash flow, which reflects a company's cash-generating ability. |
| Free Cash Flow | $730,950,016 | Free cash flow, after deducting capital expenditures, which can be used for dividends or reinvestment. |
| Gross Margin | 33.13% | Gross margin; a higher value indicates stronger product profitability. |
| Operating Margin | 8.48% | Operating margin; slightly negative, indicating high operating costs. |
| Profit Margin | -1.25% | Net profit margin, which reflects overall profitability. |
AVTR Leverage & Financial Health Indicators Shows key metrics that reflect debt levels, liquidity, and overall financial stability
| Field | Value | Description |
|---|---|---|
| Debt/Equity Ratio | 69.26% | Low leverage level, indicating the company has low debt pressure. |
| Total Debt | $3,857,900,032 | Used together with cash and EBITDA to assess debt-paying ability. |
AVTR Growth Indicators Shows key financial metrics that reflect profitability, cash flow, and business expansion
| Field | Value | Description |
|---|---|---|
| Revenue Growth (YoY) | -5.30% | Rapid revenue growth, indicating fast business expansion. |
| Earnings Growth (YoY) | 0.00% | Significant EPS growth, indicating rapid improvement in profitability. |
Financial Data for AVTR (Key ratios, margins, and cash flow)
| Field | Value | Description |
|---|---|---|
| Current Price | $11.58 | Latest stock trading price |
| Price Target (High) | $19 | Analyst highest expected price |
| Price Target (Low) | $12 | Analyst lowest expected price |
| Price Target (Average) | $13.64 | Average target price across analysts |
| Price Target (Median) | $13 | Median of target prices |
| Average Rating Score | 2.44 | Average analyst rating (1=Strong Buy, 5=Sell) |
| Consensus Recommendation | buy | Consensus rating |
| Analyst Coverage Count | 14 | Number of analysts providing estimates |
| Cash Holdings | $251,900,000 | Total cash held by the company |
| Cash per Share | $0.37 | Cash value per outstanding share |
| Total Debt | $3,857,900,032 | Company's total debt |
| Quick Ratio | 0.877 | Ability to cover short-term liabilities (excludes inventory) |
| Current Ratio | 1.488 | Overall short-term liquidity |
| Debt/Equity Ratio | 69.26% | Leverage ratio: Debt / Equity |
| EBITDA | $1,080,600,064 | Earnings before interest, taxes, depreciation & amortization |
| Total Revenue | $6,575,200,256 | Total company revenue |
| Revenue per Share | $9.653 | Total revenue divided by shares outstanding |
| Gross Profit | 33.13% | Revenue minus cost of goods sold |
| Return on Assets | 3.43% | Net income / Total assets |
| Return on Equity | -1.48% | Net income / Shareholder equity |
| Earnings Growth (YoY) | 0.00% | Year-over-year EPS growth |
| Revenue Growth (YoY) | -5.30% | Year-over-year revenue growth |
| Gross Margin | 33.13% | Gross profit / Total revenue |
| EBITDA Margin | 16.43% | EBITDA / Revenue |
| Operating Margin | 8.48% | Operating income / Revenue |
| Profit Margin | -1.25% | Net income / Revenue |
| Free Cash Flow | $730,950,016 | Cash left after capital expenditures |
| Operating Cash Flow | $644,400,000 | Cash from core business operations |
| Currency | USD | Reported in US dollars |
| Last Updated | 2025-11-05 | Data source from Yahoo |